Insulin resistance as an independent predictor of metabolic dysfunction-associated steatohepatitis (MASH) severity: combined data from multiple therapeutic trials including more than 10, 000 patients

被引：0
|
作者：
Ratziu, Vlad [1 ]
Schattenberg, Jorn M. [2 ]
Alkhouri, Naim
Noureddin, Mazen [3 ,4 ]
Charlton, Michael [5 ]
Dubourg, Julie [6 ]
Harrison, Stephen A. [7 ]
机构：
[1] Sorbonne Univ, Inst Cardiometabolism & Nutr, Hosp Pitie Salpetriere, INSERM,UMRS 1138 CRC, Paris, France
[2] Saarland Univ, Med Ctr, Homburg, Germany
[3] Arizona Liver Hlth, Phoenix, AZ USA
[4] Houston Res Inst, Houston, TX USA
[5] Univ Chicago, Chicago, IL USA
[6] Summit Clin Res, San Antonio, TX USA
[7] Summit Clin Res, San Antonio, TX USA
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-199
引用
收藏
页码：S464 / S464
页数：1
相关论文
共 30 条
  • [1] Fasting Insulin as an Independent Predictor of Metabolic Dysfunction-Associated Steatohepatitis (MASH) Severity
    Harrison, Stephen A.
    Dubourg, Julie
    Jeannin, Sophie
    Colca, Jerry R.
    Ratziu, Vlad
    DIABETES, 2024, 73
  • [2] Association of plasma magnesium with MASH and cirrhosis: combined data from multiple therapeutic trials including more than 10, 000 patients
    Harrison, Stephen A.
    Dubourg, Julie
    Ratziu, Vlad
    Schattenberg, Joern M.
    Alkhouri, Naim
    Noureddin, Mazen
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2024, 80 : S481 - S482
  • [3] CLINICAL, BIOLOGICAL AND IMAGING PREDICTORS OF AT-RISK METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH): COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 6,000 PATIENTS (IN COLLABORATION WITH NAIL-NIT CONSORTIUM)
    Harrison, Stephen A.
    Dubourg, Julie
    Alkhouri, Naim
    Noureddin, Mazen
    Schattenberg, Joern M.
    Jeannin, Sophie
    HEPATOLOGY, 2023, 78 : S249 - S253
  • [4] Association between uric acid concentration and MASH: combined data from multiple therapeutic trials including more than 10, 000 patients
    Harrison, Stephen A.
    Dubourg, Julie
    Ratziu, Vlad
    Schattenberg, Joern M.
    Alkhouri, Naim
    Noureddin, Mazen
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2024, 80 : S482 - S482
  • [5] Exploring racial, ethnic, and demographics representativeness in MASH clinical trials: combined data from multiple therapeutic trials including more than 10, 000 patients
    Schattenberg, Jorn M.
    Alkhouri, Naim
    Noureddin, Mazen
    Ratziu, Vlad
    Charlton, Michael
    Dubourg, Julie
    Harrison, Stephen A.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S648 - S649
  • [6] Clinical, biological and imaging predictors of at-risk MASH: combined data from multiple therapeutic trials including more than 10, 000 patients
    Harrison, Stephen A.
    Dubourg, Julie
    Alkhouri, Naim
    Noureddin, Mazen
    Schattenberg, Joern M.
    Jeannin, Sophie
    Ratziu, Vlad
    Charlton, Michael
    JOURNAL OF HEPATOLOGY, 2024, 80 : S504 - S505
  • [7] GLYCEMIC CONTROL PREDICTS ADVANCED FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 4,000 LIVER BIOPSY DATA
    Rinella, Mary
    Dubourg, Julie
    Ratziu, Vlad
    Alkhouri, Naim
    Jeannin, Sophie
    Schattenberg, Joern
    Noureddin, Mazen
    Charlton, Michael
    Harrison, Stephen
    HEPATOLOGY, 2024, 80 : S649 - S650
  • [8] The infamous ballooned hepatocye-fact or fiction: combined data from multiple therapeutic trials including more than 10, 000 patients
    Dubourg, Julie
    Ratziu, Vlad
    Schattenberg, Jorn M.
    Noureddin, Mazen
    Alkhouri, Naim
    Charlton, Michael
    Harrison, Stephen A.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S463 - S463
  • [9] ASSOCIATION BETWEEN RENAL FUNCTION AND NONALCOHOLIC STEATOHEPATITIS ( NASH) SEVERITY: COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 6,000 PATIENTS ( IN COLLABORATION WITH NAIL- NIT CONSORTIUM)
    Harrison, Stephen A.
    Dubourg, Julie
    Jeannin, Sophie
    Alkhouri, Naim
    Schattenberg, Joern M.
    Noureddin, Mazen
    HEPATOLOGY, 2023, 78 : S768 - S771
  • [10] DESCRIPTION OF DIVERSITY IN NONALCOHOLIC STEATOHEPATITIS (NASH) CLINICAL TRIALS: COMBINED DATA FROM MULTIPLE THERAPEUTIC TRIALS INCLUDING MORE THAN 6,000 PATIENTS ( IN COLLABORATION WITH NAIL-NIT CONSORTIUM)
    Alkhouri, Naim
    Jeannin, Sophie
    Dubourg, Julie
    Schattenberg, Joern M.
    Rich, Nicole E.
    Harrison, Stephen A.
    Noureddin, Mazen
    HEPATOLOGY, 2023, 78 : S939 - S943
123